栄研化学(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4549/E00961 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/01/23 | 日証協 | 290,930株 | -2.82% | 90,500株 | +286.87% | 308,046株 | -20.8% | 6,786株 | +17% |
2015/01/16 | 日証協 | 299,360株 | -0.22% | 23,393株 | -90.97% | 388,961株 | +0.3% | 5,800株 | -97.08% |
2015/01/09 | 日証協 | 300,015株 | +70.11% | 259,048株 | +727.63% | 387,816株 | +30.49% | 198,855株 | +2867.99% |
2014/12/30 | 日証協 | 176,363株 | +2.05% | 31,300株 | +100.45% | 297,209株 | -8.46% | 6,700株 | +235% |
2014/12/26 | 日証協 | 172,815株 | +2.87% | 15,615株 | -66.45% | 324,661株 | +8.27% | 2,000株 | -99.11% |
2014/12/19 | 日証協 | 168,000株 | +81.82% | 46,548株 | -22.48% | 299,861株 | +234.16% | 224,112株 | +646.74% |
2014/12/12 | 日証協 | 92,400株 | +3.01% | 60,048株 | +63.62% | 89,737株 | +17.65% | 30,012株 | +248.98% |
2014/12/05 | 日証協 | 89,700株 | +9.84% | 36,700株 | +339.63% | 76,275株 | +7.92% | 8,600株 | +19.44% |
2014/11/28 | 日証協 | 81,662株 | -6.2% | 8,348株 | -28.65% | 70,675株 | -3.67% | 7,200株 | -39.01% |
2014/11/21 | 日証協 | 87,062株 | -3.76% | 11,700株 | +30.76% | 73,370株 | +1.1% | 11,806株 | +743.29% |
2014/11/14 | 日証協 | 90,462株 | -38.22% | 8,948株 | +77.61% | 72,570株 | -10.98% | 1,400株 | -84.78% |
2014/11/07 | 日証協 | 146,433株 | +3.73% | 5,038株 | -86.34% | 81,525株 | +27.44% | 9,200株 | -46.37% |
2014/10/31 | 日証協 | 141,164株 | -9.36% | 36,869株 | +4.14% | 63,970株 | -37.11% | 17,155株 | -22.55% |
2014/10/24 | 日証協 | 155,748株 | +0.97% | 35,404株 | -55.91% | 101,720株 | +2.47% | 22,150株 | -54.05% |
2014/10/17 | 日証協 | 154,248株 | +3.06% | 80,300株 | +270.85% | 99,270株 | -31.19% | 48,200株 | +447.73% |
2014/10/10 | 日証協 | 149,663株 | -9.98% | 21,653株 | -85.67% | 144,270株 | -15.91% | 8,800株 | -92.53% |
2014/10/03 | 日証協 | 166,248株 | +13.48% | 151,051株 | +27.9% | 171,570株 | -9.47% | 117,865株 | +287.71% |
2014/09/26 | 日証協 | 146,500株 | +1.45% | 118,100株 | +38.45% | 189,511株 | -21.94% | 30,400株 | -69.57% |
2014/09/19 | 日証協 | 144,400株 | +51.36% | 85,303株 | +132.41% | 242,770株 | +68.29% | 99,906株 | +2856.67% |
※株式分割は考慮していませんのでご注意ください。
Page Top